19 results
8-K
EX-10.1
CFMS
Conformis Inc
27 May 21
Departure of Directors or Certain Officers
5:23pm
.
(ii)Voting Rights. A Participant shall have no voting rights with respect to any Restricted Stock Units.
(iii)Dividend Equivalents. The Award
PRE 14A
CFMS
Conformis Inc
30 Mar 21
Preliminary proxy
5:29pm
, on a mandatory basis or at the election of the Participant in a manner that complies with Section 409A of the Code.
(2) Voting Rights. A Participant shall have … no voting rights with respect to any Restricted Stock Units.
(3) Dividend Equivalents. The Award agreement for Restricted Stock Units may provide
8-K
EX-1.1
CFMS
Conformis Inc
17 Feb 21
Conformis, Inc. Announces Pricing of $85 Million Underwritten Offering of Common Stock
4:01pm
, security interest, claim, limitation on voting rights, equity, trust or other encumbrance, preferential arrangement, defect or restriction of any kind … or imposition of any lien, charge, mortgage, pledge, security interest, claim, limitation on voting rights, equity, trust or other encumbrance, preferential
424B5
CFMS
Conformis Inc
11 Feb 21
Prospectus supplement for primary offering
4:12pm
.
Voting Rights. Each holder of common stock is entitled to one vote for each share held on all matters to be voted upon by stockholders.
Dividends … cumulative voting rights. Holders of shares of the common stock are not required to make additional capital contributions.
NASDAQ Global Select Market
424B5
xbcyb7kksd4r
25 Sep 20
Prospectus supplement for primary offering
4:08pm
8-K
EX-4.2
4wh00f0bokqu5btwd7x
24 Sep 20
Conformis, Inc. Announces $17.25 Million Registered Direct Offering Priced At-The-Market
8:54am
8-K
EX-1.1
667wnjb8wcbjau3jaid
24 Sep 20
Conformis, Inc. Announces $17.25 Million Registered Direct Offering Priced At-The-Market
8:54am
8-K
EX-4.1
cooqco
24 Sep 20
Conformis, Inc. Announces $17.25 Million Registered Direct Offering Priced At-The-Market
8:54am
424B5
e0gs3
6 Aug 20
Prospectus supplement for primary offering
12:00am
424B5
z8afx0f4tet5 5l288w8
6 Aug 20
Prospectus supplement for primary offering
12:00am
8-K
EX-10.1
ka5iapna502ga
26 Jun 19
Conformis Secures Up to $30 Million in Debt Financing and $3 Million in Equity Financing from Innovatus Life Sciences and East West Bank
12:00am
424B5
kwtfmjtpw
18 Dec 18
Prospectus supplement for primary offering
2:22pm
10-K
vbk77z8ke76796w6qa
24 Mar 16
Annual report
12:00am
10-Q
srvfckniy ph1k8
14 Aug 15
Quarterly report
12:00am
- Prev
- 1
- Next